Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)

被引:29
作者
Berntson, Lillemor [1 ]
Nordal, Ellen [2 ,3 ]
Fasth, Anders [4 ]
Aalto, Kristiina [5 ]
Herlin, Troels [6 ]
Nielsen, Susan [7 ]
Rygg, Marite [8 ,9 ]
Zak, Marek [7 ]
Ronnelid, Johan [10 ]
机构
[1] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden
[2] Univ Hosp North Norway, Dept Pediat, Tromso, Norway
[3] Univ Tromso, Inst Clin Med, Tromso, Norway
[4] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden
[5] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat, Helsinki, Finland
[6] Aarhus Univ, Aarhus, Denmark
[7] Rigshosp, Univ Clin Pediat 2, DK-2100 Copenhagen, Denmark
[8] Norwegian Univ Sci & Technol, Dept Lab Med,Childrens & Womens Hlth, N-7034 Trondheim, Norway
[9] St Olavs Hosp, Dept Pediat, Trondheim, Norway
[10] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Arthritis; Juvenile Idiopathic Arthritis; Anti-CCP; Rheumatoid factor; Anti-collagen type II antibodies; Child; Joints; CYCLIC CITRULLINATED PEPTIDE; EARLY RHEUMATOID-ARTHRITIS; TUMOR-NECROSIS-FACTOR; DISEASE-ACTIVITY; PROTEIN/PEPTIDE ANTIBODIES; CRITERIA; CLASSIFICATION; PREVALENCE; SEVERITY; PROGRESSION;
D O I
10.1186/1546-0096-12-22
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Background: Early appearance of antibodies specific for native human type II collagen (anti-CII) characterizes an early inflammatory and destructive phenotype in adults with rheumatoid arthritis (RA). The objective of this study was to investigate the occurrence of anti-CII, IgM RF, IgA RF and anti-CCP in serum samples obtained early after diagnosis, and to relate the occurrence of autoantibodies to outcome after eight years of disease in children with juvenile idiopathic arthritis (JIA). Methods: The Nordic JIA database prospectively included JIA patients followed for eight years with data on remission and joint damage. From this database, serum samples collected from 192 patients, at a median of four months after disease onset, were analysed for IgG anti-CII, IgM RF, IgA RF and IgG anti-CCP. Joint damage was assessed based on Juvenile Arthritis Damage Index for Articular damage (JADI-A), a validated clinical instrument for joint damage. Results: Elevated serum levels of anti-CII occurred in 3.1%, IgM RF in 3.6%, IgA RF in 3.1% and anti-CCP in 2.6% of the patients. Occurrence of RF and anti-CCP did to some extent overlap, but rarely with anti-CII. The polyarticular and oligoarticular extended categories were overrepresented in patients with two or more autoantibodies. Anti-CII occurred in younger children, usually without overlap with the other autoantibodies and was associated with high levels of C-reactive protein (CRP) early in the disease course. All four autoantibodies were significantly associated with joint damage, but not with active disease at the eight-year follow up. Conclusions: Anti-CII, anti-CCP, IgA RF and IgM RF detected early in the disease course predicted joint damage when assessed after eight years of disease. The role of anti-CII in JIA should be further studied.
引用
收藏
页数:7
相关论文
共 35 条
[1]
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative [J].
Aletaha, Daniel ;
Neogi, Tuhina ;
Silman, Alan J. ;
Funovits, Julia ;
Felson, David T. ;
Bingham, Clifton O., III ;
Birnbaum, Neal S. ;
Burmester, Gerd R. ;
Bykerk, Vivian P. ;
Cohen, Marc D. ;
Combe, Bernard ;
Costenbader, Karen H. ;
Dougados, Maxime ;
Emery, Paul ;
Ferraccioli, Gianfranco ;
Hazes, Johanna M. W. ;
Hobbs, Kathryn ;
Huizinga, Tom W. J. ;
Kavanaugh, Arthur ;
Kay, Jonathan ;
Kvien, Tore K. ;
Laing, Timothy ;
Mease, Philip ;
Menard, Henri A. ;
Moreland, Larry W. ;
Naden, Raymond L. ;
Pincus, Theodore ;
Smolen, Josef S. ;
Stanislawska-Biernat, Ewa ;
Symmons, Deborah ;
Tak, Paul P. ;
Upchurch, Katherine S. ;
Vencovsky, Jiri ;
Wolfe, Frederick ;
Hawker, Gillian .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2569-2581
[2]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis [J].
Avcin, T ;
Cimaz, R ;
Falcini, F ;
Zulian, F ;
Martini, G ;
Simonini, G ;
Porenta-Besic, V ;
Cecchini, G ;
Borghi, MO ;
Meroni, PL .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) :608-611
[4]
Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis [J].
Bas, S ;
Genevay, S ;
Meyer, O ;
Gabay, C .
RHEUMATOLOGY, 2003, 42 (05) :677-680
[5]
Berntson L, 2003, J RHEUMATOL, V30, P2275
[6]
High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor a inhibitors in rheumatoid arthritis [J].
Bobbio-Pallavicini, Francesca ;
Caporali, Roberto ;
Alpini, Claudia ;
Avalle, Stefano ;
Epis, Oscar M. ;
Klersy, Catherine ;
Montecucco, Carlomaurizio .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (03) :302-307
[7]
Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis - Results from the Norfolk Arthritis Register study, a large inception cohort [J].
Bukhari, M ;
Lunt, M ;
Harrison, BJ ;
Scott, DGI ;
Symmons, DPM ;
Silman, AJ .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :906-912
[8]
Antibodies to type II collagen in early rheumatoid arthritis - Correlation with disease progression [J].
Cook, AD ;
Rowley, MJ ;
Mackay, IR ;
Gough, A ;
Emery, P .
ARTHRITIS AND RHEUMATISM, 1996, 39 (10) :1720-1727
[9]
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis [J].
Dewint, P ;
Hoffman, IEA ;
Rogge, S ;
Joos, R ;
Union, A ;
Dehoorne, J ;
Delanghe, J ;
Veys, EM ;
De Keyser, F ;
Elewaut, D .
RHEUMATOLOGY, 2006, 45 (02) :204-208
[10]
Gilliam BE, 2008, CLIN EXP RHEUMATOL, V26, P492